Giulia Lanzolla

Via Università 40
Cagliari, 09124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists.

Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists.

Journal: Vision (Basel, Switzerland)

Published: April 13, 2026

Does preoperative administration of Lugol's solution in patients undergoing thyroidectomy for Graves' disease really improve surgical outcomes? A propensity score matching analysis from six high-volume centers (StELLinA study).

Does preoperative administration of Lugol's solution in patients undergoing thyroidectomy for Graves' disease really improve surgical outcomes? A propensity score matching analysis from six high-volume centers (StELLinA study).

Journal: Updates in surgery

Published: February 21, 2026

Serum mTOR: an associative marker of Graves' orbitopathy.

Serum mTOR: an associative marker of Graves' orbitopathy.

Journal: Journal of endocrinological investigation

Published: February 03, 2026

De-Escalating Thyroid Cancer Surgery: Insights and Unresolved Questions From the 2025 ATA Guidelines.

De-Escalating Thyroid Cancer Surgery: Insights and Unresolved Questions From the 2025 ATA Guidelines.

Journal: Annali italiani di chirurgia

Published: December 17, 2025

Light Discomfort Thresholds in Patients with Moderate-to-Severe Active versus Mild Non-Active Thyroid Eye Disease.

Light Discomfort Thresholds in Patients with Moderate-to-Severe Active versus Mild Non-Active Thyroid Eye Disease.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: November 04, 2025

Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression.

Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 26, 2025

Risk of Complications in Patients Undergoing Thyroidectomy for Graves' Disease (LUNA Study).

Risk of Complications in Patients Undergoing Thyroidectomy for Graves' Disease (LUNA Study).

Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Published: October 04, 2025

Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61".

Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61".

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 20, 2025

Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms.

Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms.

Journal: European journal of endocrinology

Published: August 12, 2025

Risk of Neck Hematoma Following Thyroidectomy in Patients Taking Direct Oral Anticoagulants: A Propensity Score Matching Analysis from Nine High-Volume European Centers (RAGNO Study).

Risk of Neck Hematoma Following Thyroidectomy in Patients Taking Direct Oral Anticoagulants: A Propensity Score Matching Analysis from Nine High-Volume European Centers (RAGNO Study).

Journal: Journal of clinical medicine

Published: April 04, 2025

Graves' Disease: Is It Time for Targeted Therapy? A Narrative Review.

Graves' Disease: Is It Time for Targeted Therapy? A Narrative Review.

Journal: Medicina (Kaunas, Lithuania)

Published: February 16, 2025

Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study.

Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: February 05, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026